In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Feeling worn out and weighed down lately? A bogged-down liver could be to blame. Burning fat, filtering toxins and keeping blood sugar and cholesterol in healthy balance are just a few of the 500-plus ...

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...

Fatty liver disease, now called steatotic liver disease (SLD), is a condition caused by a buildup of fat in the liver. There are two main types of SLD: metabolic dysfunction-associated steatotic liver ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

Fatty liver disease happens when fat builds up in your liver. This can cause damage, inflammation, and other complications. There are two main types of fatty liver disease: Nonalcoholic fatty liver ...

Non-Alcoholic Fatty Liver Disease (NAFLD) is soaring in the U.S., now affecting up to 30% of adults. But new medical advice ...

Drinking diet soda may be tied to an increased risk of metabolic dysfunction-associated steatotic liver disease, according to a study.

It usually takes years for fatty liver disease to progress to cirrhosis, but several factors affect the timeline. Fatty liver disease is the buildup of fat in your liver, which can lead to ...

Fatty liver disease typically presents the same in both females and males. However, research has found that the risk for females rises significantly after menopause. Though fatty liver disease is much ...